Underlying Volume Growth (UVG)
4%
+4pp YoY
Highest UVG in 12 quarters, driven by broad-based volume recovery across all categories.
HINDUNILVR
Consumer
23 Jan 2026
Hindunilvr Ltd — Q3 FY26
HUL delivered a steady Q3 FY26 with 6% revenue growth and 4% underlying volume growth, the highest in 12 quarters.
Financial stats pending filing verification
2-Minute Summary
✦ AI-Generated from Full Transcript
HUL delivered a steady Q3 FY26 with 6% revenue growth and 4% underlying volume growth, the highest in 12 quarters. Growth was broad-based across all segments, with home care gaining its highest-ever market share and beauty & well-being led by double-digit hair care growth. EBITDA margin at 23.3% remained within the guided range, while PAT before exceptional items grew 1% to INR 2,562 crore. Management cited improving macros (lower inflation, supportive RBI policy) and internal actions (quick commerce organization, portfolio transformation) as key drivers. Guidance: H2 FY26 better than H1, and FY27 better than FY26, with margins staying in the 22-23% range. Risk: volatile input costs and currency depreciation could pressure margins if pricing actions lag.
HUL ने वित्त वर्ष 2026 की तीसरी तिमाही में अच्छा प्रदर्शन किया। कंपनी की कमाई में 6% और बिक्री की मात्रा में 4% की बढ़ोतरी हुई, जो पिछले 12 तिमाहियों में सबसे ज्यादा है। घरेलू देखभाल उत्पादों ने सबसे ज्यादा बाजार हिस्सेदारी हासिल की, जबकि बालों की देखभाल में दो अंकों की वृद्धि हुई। कंपनी का मुनाफा 1% बढ़कर 2,562 करोड़ रुपये रहा। प्रबंधन ने कहा कि महंगाई कम होने और RBI की मदद से हालात बेहतर हो रहे हैं। उन्होंने यह भी कहा कि अगली तिमाही इससे बेहतर रहेगी और अगले वित्त वर्ष में और सुधार होगा। हालांकि, कच्चे माल की कीमतें बढ़ने और रुपये के कमजोर होने से मुनाफे पर दबाव पड़ सकता है।
Key Numbers
Quick Commerce Share of Business
3%
+100% QoQ
Quick commerce is doubling every quarter; HUL set up a dedicated organization to capture this channel.
D2C Brands ARR (Minimalist + OZiva)
INR 1,100 crore
N/A
Combined annualized revenue run-rate of Minimalist and OZiva, reflecting strong D2C scaling.
Quick Commerce Service Level Improvement
1,400 bps
+1400bps YoY
Availability improved by 1,400 basis points over the past year due to supply chain investments.
What Changed vs Last Quarter
UPDATED
FY27 revenue growth better than FY26
Management expects FY27 top-line growth to exceed FY26, driven by improving macros and internal actions.
UPDATED
H2 FY26 better than H1 FY26
Second half of FY26 is expected to show stronger growth than the first half, with Q3 as a normalized base.
UPDATED
EBITDA margin to stay in 22-23% range
Consolidated EBITDA margin will remain within the guided range of 22-23% (excluding ice cream), as growth investments are prioritized.
UPDATED
Low single-digit price increases expected over FY27
Calibrated price increases across portfolio, especially in home care, to offset input cost inflation.
DROPPED
Ice cream demerger timeline
Ice cream demerger expected to complete in December quarter, with listing in Q4 FY26, subject to regulatory approvals.
NEW RISK
Input cost volatility and currency depreciation
Depreciating rupee and divergent commodity trends (palm oil, tea, crude derivatives) could pressure margins if price increases lag.
NEW RISK
Competitive pressure in home care pricing
Home care pricing has been negative for an extended period due to competitive intensity; recovery may be gradual.
NEW RISK
Skincare growth lagging behind premium platforms
Analyst noted HUL's skincare growth is meaningfully lower than platforms like Nykaa; management attributed to portfolio breadth but did not quantify gap.
NEW RISK
GST transition impact on volumes
October saw destocking due to GST 2.0 rollout; while November restocked, any future policy changes could disrupt volumes.
RISK GONE
Prolonged GST disruption
GST transition impact may extend beyond October, with trade restocking taking a couple of months to normalize.
RISK GONE
Weather impact on winter categories
Prolonged monsoon and potential weak winter could dampen demand for seasonal products like skincare and ice cream.
RISK GONE
Competitive pressure in core categories
Analyst raised concern about digital-first competition and need to focus on mid and bottom of pyramid; management acknowledged need for sharper segmentation.
RISK GONE
Slow premiumization in body wash
Body wash liquids penetration remains at only 2%, indicating slower adoption despite management's focus on premiumization.
🤫 Topics management stopped discussing
Mentioned in Q1 FY25, Q2 FY25, Q3 FY25, Q4 FY25
Inflation in palm oil, tea, and coffee not fully priced in, while deflation in crude oil is passed on quickly, creating a price-cost gap.
Mentioned in Q1 FY26, Q2 FY26, Q3 FY25
Ice cream demerger expected to complete in December quarter, with listing in Q4 FY26, subject to regulatory approvals.
Mentioned in Q1 FY25, Q1 FY26
Management acknowledged price decreases in home care due to both commodity deflation and competitive pressures, which could pressure margins and pricing power.
Mentioned in Q1 FY26, Q4 FY25
Management expects EBITDA margin to remain in the 22%-23% range for the next few quarters, with sequential gross margin improvement reinvested into the business.
Mentioned in Q1 FY25, Q2 FY25
Management aims to keep EBITDA margin at current ~23.8% levels, with some basis points fluctuation, through productivity savings and calibrated pricing.
Management Guidance
FY27 revenue growth better than FY26
Management expects FY27 top-line growth to exceed FY26, driven by improving macros and internal actions.
Management guidance revenueH2 FY26 better than H1 FY26
Second half of FY26 is expected to show stronger growth than the first half, with Q3 as a normalized base.
Management guidance growthEBITDA margin to stay in 22-23% range
Consolidated EBITDA margin will remain within the guided range of 22-23% (excluding ice cream), as growth investments are prioritized.
Management guidance marginsLow single-digit price increases expected over FY27
Calibrated price increases across portfolio, especially in home care, to offset input cost inflation.
Management guidance revenueKey Risks
Input cost volatility and currency depreciation
Depreciating rupee and divergent commodity trends (palm oil, tea, crude derivatives) could pressure margins if price increases lag.
high · management_commentaryCompetitive pressure in home care pricing
Home care pricing has been negative for an extended period due to competitive intensity; recovery may be gradual.
medium · analyst_questionSkincare growth lagging behind premium platforms
Analyst noted HUL's skincare growth is meaningfully lower than platforms like Nykaa; management attributed to portfolio breadth but did not quantify gap.
medium · analyst_questionGST transition impact on volumes
October saw destocking due to GST 2.0 rollout; while November restocked, any future policy changes could disrupt volumes.
low · data_observationNotable Quotes
Our UVG for the quarter is the highest UVG that we have recorded in the last twelve quarters, so this bodes well for us, and this is where we will keep focusing.
Growth will continue to remain our number 1 priority. We will invest in the business as needed to support sustained growth, and hence we expect consolidated EBITDA margin to stay around the guided range.
Winning in India will always require an 'and' strategy rather than an 'or' strategy.
Frequently Asked Questions
What was Hindunilvr's revenue in Q3 FY26?
Hindunilvr reported revenue of — in Q3 FY26, representing a +6% change compared to the same quarter last year.
What guidance did Hindunilvr management give for FY27?
FY27 revenue growth better than FY26: Management expects FY27 top-line growth to exceed FY26, driven by improving macros and internal actions. H2 FY26 better than H1 FY26: Second half of FY26 is expected to show stronger growth than the first half, with Q3 as a normalized base. EBITDA margin to stay in 22-23% range: Consolidated EBITDA margin will remain within the guided range of 22-23% (excluding ice cream), as growth investments are prioritized. Low single-digit price increases expected over FY27: Calibrated price increases across portfolio, especially in home care, to offset input cost inflation.
What are the key risks for Hindunilvr in FY27?
Key risks include Input cost volatility and currency depreciation — Depreciating rupee and divergent commodity trends (palm oil, tea, crude derivatives) could pressure margins if price increases lag.; Competitive pressure in home care pricing — Home care pricing has been negative for an extended period due to competitive intensity; recovery may be gradual.; Skincare growth lagging behind premium platforms — Analyst noted HUL's skincare growth is meaningfully lower than platforms like Nykaa; management attributed to portfolio breadth but did not quantify gap.; GST transition impact on volumes — October saw destocking due to GST 2.0 rollout; while November restocked, any future policy changes could disrupt volumes..
Did Hindunilvr meet its previous quarter's guidance?
Of 4 tracked promises, management 0 met, 0 close, 4 missed.
Where can I read the full Hindunilvr Q3 FY26 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.